LB Pharmaceuticals Inc Common Stock

LBRX

LBRXLB Pharmaceuticals Inc Common Stock US flag

NASDAQ Global Select

33.95

USD

+0.52

- -

973.57MMarket Cap

Income Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	3	11	65	30
+ Selling, General & Admin	1	4	14	14
+ Research & Development	1	8	51	17
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-3	-11	-65	-30
- Non-Operating (Income) Loss	12	-5	-2	-5
+ Interest Expense, Net	2	4	-2	-4
+ Interest Expense	2	5	- -	- -
- Interest Income	- -	1	2	4
+ Other Non-Op (Income) Loss	9	-9	- -	-1
Pretax Income	-14	-6	-63	-25
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-14	-6	-63	-25
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-14	-6	-63	-25
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-14	-6	-63	-25
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-14	-6	-63	-25
EBIT	-3	-11	-65	-30
EBITDA	-3	-11	-65	-30
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	-3	-11	-65	-30
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	4	4	4	8
Basic EPS, GAAP	-4.05	-1.77	-17.82	-3.13
Basic EPS from Cont Ops	-4.05	-1.77	-17.82	-3.13
Diluted Weighted Avg Shares	22	22	22	8
Diluted EPS, GAAP	-0.64	-0.28	-2.81	-3.13
Diluted EPS from Cont Ops	-0.64	-0.28	-2.81	-3.13

Balance Sheet (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	21	46	29	308
+ Cash, Cash Equivalents & STI	21	43	28	295
+ Cash & Cash Equivalents	21	15	23	250
+ ST Investments	- -	28	5	45
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	- -	2	1	13
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	5	5
+ Property, Plant & Equip, Net	- -	- -	4	4
+ Property, Plant & Equip	- -	- -	4	4
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	1
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	1
Total Assets	21	46	34	313
+ Payables & Accruals	- -	2	5	5
+ Accounts Payable	- -	1	2	2
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	3	2
+ ST Debt	- -	- -	- -	1
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	1
+ Other ST Liabilities	- -	1	2	2
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	1	2	2
Total Current Liabilities	- -	3	8	7
+ LT Debt	24	- -	3	3
+ LT Borrowings	24	- -	- -	- -
+ LT Finance Leases	- -	- -	3	3
+ Other LT Liabilities	26	78	117	1
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	26	78	117	1
Total Noncurrent Liabilities	50	78	120	4
Total Liabilities	50	80	128	12
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	6	6	10	431
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	6	6	10	431
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-35	-41	-104	-130
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-29	-34	-95	301
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-29	-34	-95	301
Total Liabilities & Equity	21	46	34	313
Shares Outstanding	22	22	22	25
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	- -	4	4
Net Debt	3	-15	-23	-250
Net Debt to Equity	-9.52	43.45	24.3	-83.03
Tangible Common Equity Ratio	-134.06	-75.5	-281.96	96.29
Current Ratio	45.82	17.51	3.56	41.44
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-14	-6	-63	-25
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	12	-5	7	3
+ Stock-Based Compensation	- -	- -	3	4
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	3	- -
+ Other Non-Cash Adj	11	-5	- -	-1
+ Chg in Non-Cash Work Cap	- -	-1	3	-14
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-2	-2	-12
+ Inc (Dec) in Accts Payable	- -	1	5	-1
+ Inc (Dec) in Other	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-3	-12	-53	-35
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	-1	- -
+ Acq of Fixed Prod Assets	- -	- -	-1	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	328
+ Increase in Capital Stock	- -	- -	- -	328
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	-28	24	-40
+ Dec in LT Investment	- -	6	54	5
+ Inc in LT Investment	- -	-34	-30	-45
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	-28	23	-40
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	25	1	- -	- -
+ Cash From Debt	25	1	- -	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	-2	33	38	-25
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	23	34	38	303
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	20	-6	8	227
EBITDA	-3	-11	-65	-30
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	-3	-12	-54	-35
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-11	-54	-35
Free Cash Flow per Basic Share	-0.77	-3.42	-15.2	-4.38
Price/Free Cash Flow	- -	- -	- -	-5.09
Cash Flow to Net Income	0.19	1.93	0.84	1.4
Capital Expenditures	- -	- -	-1	- -